Repligen
RGEN
450 hedge funds and large institutions have $8.94B invested in Repligen in 2022 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 180 increasing their positions, 144 reducing their positions, and 94 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 180 | Existing positions reduced: 144
2.65% more ownership
Funds ownership: 85.49% → 88.13% (+2.6%)
11% less funds holding
Funds holding: 507 → 450 (-57)
20% less call options, than puts
Call options by funds: $48.4M | Put options by funds: $60.6M
28% less capital invested
Capital invested by funds: $12.5B → $8.94B (-$3.52B)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
55% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 94
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$139M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$84.5M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$45.9M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$34.3M |
| 5 |
BlackRock
New York
|
+$33.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
-$65.6M |
| 2 |
Millennium Management
New York
|
-$57.9M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$43.4M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$41.4M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$41M |
RGEN Hedge Fund Activity: Q1 2022 in Review
450 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Repligen (RGEN) for Q1 2022, worth a combined $8.94B — down 28% from $12.5B a quarter earlier.
Sellers outnumbered buyers: 94 funds closed out of RGEN and 42 opened new positions — a net loss of 52 holders — while 144 trimmed existing stakes and 180 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $139M. The largest seller was Ardevora Asset Management, exiting entirely with an estimated $65.6M sold.
- 450 institutional investors held Repligen (RGEN) as of Q1 2022, down from 507 in Q4 2021.
- Funds reported $8.94B of Repligen stock for Q1 2022, down 28% quarter-over-quarter.
- 42 funds opened new Repligen positions in Q1 2022 and 94 closed out, a net change of -52 holders.
- The largest Repligen buyer in Q1 2022 was T. Rowe Price Associates, an estimated $139M added.
- The largest Repligen seller in Q1 2022 was Ardevora Asset Management, an estimated $65.6M sold.
Based on aggregated 13F filings for Q1 2022.